These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2437718

  • 21. Conjugate vaccines against Pseudomonas aeruginosa and malaria.
    Cryz SJ, Sadoff JC, Que JU.
    Contrib Microbiol Immunol; 1989; 10():166-89. PubMed ID: 2510972
    [No Abstract] [Full Text] [Related]

  • 22. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ, Roy R, Gamian A.
    J Immunol; 1986 Sep 01; 137(5):1708-13. PubMed ID: 3091688
    [Abstract] [Full Text] [Related]

  • 23. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
    Boutonnier A, Villeneuve S, Nato F, Dassy B, Fournier JM.
    Infect Immun; 2001 May 01; 69(5):3488-93. PubMed ID: 11292781
    [Abstract] [Full Text] [Related]

  • 24. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide.
    Pier GB, Pollack M.
    Infect Immun; 1989 Feb 01; 57(2):426-31. PubMed ID: 2492260
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
    Evenberg D, Hoogerhout P, van Boeckel CA, Rijkers GT, Beuvery EC, van Boom JH, Poolman JT.
    J Infect Dis; 1992 Jun 01; 165 Suppl 1():S152-5. PubMed ID: 1588151
    [Abstract] [Full Text] [Related]

  • 27. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
    Pier GB, Thomas DM.
    J Infect Dis; 1983 Aug 01; 148(2):206-13. PubMed ID: 6411830
    [Abstract] [Full Text] [Related]

  • 28. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.
    Cryz SJ, Sadoff JC, Fürer E.
    Infect Immun; 1988 Jul 01; 56(7):1829-30. PubMed ID: 2454893
    [Abstract] [Full Text] [Related]

  • 29. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES, Lam JS.
    FEMS Microbiol Rev; 1997 Nov 01; 21(3):243-77. PubMed ID: 9451816
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
    Bartoloni A, Norelli F, Ceccarini C, Rappuoli R, Costantino P.
    Vaccine; 1995 Apr 01; 13(5):463-70. PubMed ID: 7543714
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ, Lugowski C.
    J Immunol; 1981 Sep 01; 127(3):1011-8. PubMed ID: 6790606
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
    Gupta RK, Egan W, Bryla DA, Robbins JB, Szu SC.
    Infect Immun; 1995 Aug 01; 63(8):2805-10. PubMed ID: 7542631
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.
    Pier GB, Bennett SE.
    J Clin Invest; 1986 Feb 01; 77(2):491-5. PubMed ID: 3080477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.